Episode Appearances
Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders · May 7, 2026
250: How T Cell Activation Redefines TIL and CAR-T Manufacturing (Boosting Success Rates to 95%) with Chantale Bernatchez - Part 2
“Discusses CTMC's patient-adjacent manufacturing model, global technology transfer alliance, and next-generation cell therapy approaches”
TIL (Tumor-Infiltrating Lymphocyte) Manufacturing and Process DevelopmentCAR-T Cell Therapy Manufacturing and Next-Generation DesignsDecentralized vs. Centralized Cell Therapy Manufacturing Models
View Analysis